Live Chart

O 88.8

H 90

L 88.8

VOL 1013

Bafna Pharmaceuticals Performance

Days Range

Low: ₹87.80
High: ₹90.95
Previous Close ₹87.70
Open ₹88.80
Volume 8,442
Day’s Range ₹87.80 - ₹90.95
52W Range ₹77.05 - ₹124.45
Market Cap ₹204.01 Cr

Fundamentals of Bafna Pharmaceuticals

ROCE (TTM) NA
P/E Ratio (TTM) NA
P/B Ratio 4.3
Industry P/E 31.74
Debt to Equity 2.88
ROE NA
EPS (TTM) NA
Dividend Yield NA
Book Value 22
Face Value 10

Financials of Bafna Pharmaceuticals

Sep 2018Jun 2019Sep 2019
Net Sales8.846.8511.57
Expenses9.4110.7312.66
Profit before tax-1.22-3.71-0.55
Operating Profit-1.28-2.13-0.59
Net Profit-1.28-2.13-0.59
EPS in Rs-0.8-0.9-0.25

About Bafna Pharmaceuticals

Bafna was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing pharmaceutical formulations of ... Read More

Parent Organisation Indian Private
Founded 1995
Managing Director Shanmugam Hemalatha
NSE Symbol BAFNAPH

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Supriya Lifescience Ltd ₹2,344.06

282.35

8.95 (-3.07%)

281.1 - 294.35
Celestial Biolabs Ltd ₹4.56

1.75

0.00 (0.00)

1.75 - 1.8
JFL Life Sciences Ltd ₹47.40

43.85

0.75 (1.74%)

43.1 - 43.85
Procter & Gamble Health Ltd ₹8,541.86

5110.1

18.85 (-0.37%)

5110 - 5178.5
Veerhealth Care Ltd ₹35.74

26

0.00 (0.00)

26 - 26

What's Trending

FAQs

What is the Share price of Bafna Pharmaceuticals (BAFNAPH)?

Bafna Pharmaceuticals (BAFNAPH) share price as of December 1, 2023, on NSE is Rs 89.55 (NSE) and Rs 90.48 (BSE) on BSE.

Can I buy Bafna Pharmaceuticals (BAFNAPH) shares?

Yes, You can buy Bafna Pharmaceuticals (BAFNAPH) shares by opening a Demat account with Angel One.

How do I buy Bafna Pharmaceuticals (BAFNAPH) from Angel One?

Bafna Pharmaceuticals (BAFNAPH) share can be brought through the following modes:
  1. Direct investment: You can buy Bafna Pharmaceuticals (BAFNAPH) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Bafna Pharmaceuticals (BAFNAPH) shares.